[Linezolid, coagulase-negative Staphylococcus and the problem of resistances].
Francisco Félix
FF
Rodríguez-Vidigal
Nieves
N
Nogales-Muñoz
Araceli
A
Vera-Tomé
Agustín
A
Muñoz-Sanz
D000081:Acetamides / Q000494:pharmacology / Q000627:therapeutic use*; D000368:Aged; D003030:Coagulase / Q000032:analysis; D003428:Cross Infection / Q000188:drug therapy* / Q000453:epidemiology / Q000382:microbiology; D024901:Drug Resistance, Multiple, Bacterial; D005260:Female; D006748:Hospital Departments / Q000706:statistics & numerical data; D017052:Hospital Mortality; D006801:Humans; D007902:Length of Stay / Q000706:statistics & numerical data; D000069349:Linezolid; D008297:Male; D008875:Middle Aged; D023303:Oxazolidinones / Q000494:pharmacology / Q000627:therapeutic use*; D013030:Spain / Q000453:epidemiology; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000453:epidemiology / Q000382:microbiology; D013210:Staphylococcus / Q000187:drug effects* / Q000201:enzymology
D000081:Acetamides; D003030:Coagulase; D023303:Oxazolidinones; D000069349:Linezolid